Lassa Fever, Nigeria, 2005–2008

Lassa Fever, Nigeria, 2005–2008

Bibliographic Details
Main Authors:	Deborah U. Ehichioya, Meike Hass, Stephan Ölschläger, Beate Becker-Ziaja, Christian O. Onyebuchi Chukwu, Jide Coker, Abdulsalam Nasidi, Osi-Ogbu Ogugua, Stephan Günther, Sunday A. Omilabu
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2010-06-01
Series:	Emerging Infectious Diseases
Subjects:	Lassa fever viruses hemorrhagic fevers arenavirus Nigeria letter
Online Access:	https://wwwnc.cdc.gov/eid/article/16/6/10-0080_article

Similar Items

Animal Models of Lassa Fever
by: Rachel A. Sattler, et al.
Published: (2020-03-01)

Mastomys natalensis and Lassa Fever, West Africa
by: Emilie Lecompte, et al.
Published: (2006-12-01)

New Lineage of Lassa Virus, Togo, 2016
by: Shannon L.M. Whitmer, et al.
Published: (2018-03-01)

Lassa fever: History, causes, effects, and reduction strategies
by: Promise Tewogbola, et al.
Published: (2020-08-01)

Detection of Lassa Virus, Mali
by: David Safronetz, et al.
Published: (2010-07-01)

Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali
by: Nafomon Sogoba, et al.
Published: (2016-04-01)

Ribavirin for Lassa Fever Postexposure Prophylaxis
by: Christiane M. Hadi, et al.
Published: (2010-12-01)

Virus–Host Interactions Involved in Lassa Virus Entry and Genome Replication
by: María Eugenia Loureiro, et al.
Published: (2019-01-01)

Lassa virus protein–protein interactions as mediators of Lassa fever pathogenesis
by: Sharon Jan, et al.
Published: (2025-02-01)

Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation
by: Niranjan Y. Sardesai, et al.
Published: (2013-07-01)

Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection
by: Lisa Oestereich, et al.
Published: (2023-06-01)

Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primates
by: Courtney Woolsey, et al.
Published: (2024-12-01)

Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus
by: Anges Yadouleton, et al.
Published: (2020-01-01)

Improving the care of Lassa fever patients: re-evaluating the use of Ribavirin and characterising cardiovascular function
by: Salam, A
Published: (2024)

Descriptive epidemiology of Lassa fever in Nigeria, 2012-2017
by: Onyebuchi Augustine Okoro, et al.
Published: (2020-09-01)

Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections
by: Sylvanus Okogbenin, et al.
Published: (2022-10-01)

A Sporadic and Lethal Lassa Fever Case in Forest Guinea, 2019
by: N’Faly Magassouba, et al.
Published: (2020-09-01)

Risk factors for Lassa fever infection among survivors at the Federal Medical Center, Owo, Ondo State, Nigeria
by: Olayinka Stephen Ilesanmi, et al.
Published: (2021-06-01)

Increase in Lassa Fever Cases in Nigeria, January–March 2018
by: Elsie A. Ilori, et al.
Published: (2019-05-01)

Laboratory Diagnosis of Lassa Fever, Liberia
by: Marcus Panning, et al.
Published: (2010-06-01)

Bibliometric analysis of global Lassa fever research (1970–2017): a 47 – year study
by: Henshaw Uchechi Okoroiwu, et al.
Published: (2018-12-01)

Lassa fever. Part 1. Etiology, epidemiology and clinical manifestations
by: Elena I. Kazachinskaia, et al.
Published: (2022-07-01)

Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developments
by: Hannah L. Murphy, et al.
Published: (2021-12-01)

Lassa fever in West African sub-region: an overview
by: O. Ogbu, et al.
Published: (2007-01-01)

Lassa Virus Infection: a Summary for Clinicians
by: Vanessa Raabe, et al.
Published: (2022-06-01)

Viral RNA and infectious virus in mucosal specimens from guinea pigs modelling early phases of lethal and non-lethal Lassa fever
by: Stephen R. Welch, et al.
Published: (2022-12-01)

Pathogenesis of Lassa Fever
by: David H. Walker, et al.
Published: (2012-10-01)

Fatal Case of Lassa Fever, Bangolo District, Côte d’Ivoire, 2015
by: Mathieu Mateo, et al.
Published: (2019-09-01)

Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever
by: Meirong Wang, et al.
Published: (2021-03-01)

Monitoring of Lassa virus infection in suspected and confirmed cases in Ondo State, Nigeria
by: Olumuyiwa Babalola Salu, et al.
Published: (2020-08-01)

Molecular confirmation of Lassa fever imported into Ghana
by: Joseph H.K. Bonney, et al.
Published: (2016-04-01)

The Importance of Lassa Fever and Its Disease Management in West Africa
by: Rachel A. Reyna, et al.
Published: (2024-02-01)

The COVID-19 Impact on the Trends in Yellow Fever and Lassa Fever Infections in Nigeria
by: Nnennaya U. Opara, et al.
Published: (2022-11-01)

Housing equity for health equity: a rights-based approach to the control of Lassa fever in post-war Sierra Leone
by: Kelly J Daniel, et al.
Published: (2013-01-01)

Lassa Virus Targeting of Anterior Uvea and Endothelium of Cornea and Conjunctiva in Eye of Guinea Pig Model
by: Joy M. Gary, et al.
Published: (2019-05-01)

Absence of Nosocomial Transmission of Imported Lassa Fever during Use of Standard Barrier Nursing Methods
by: Anna Grahn, et al.
Published: (2018-06-01)

Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in Nigeria
by: Anise N. Happi, et al.
Published: (2022-08-01)

Challenges and Opportunities in Lassa fever Control Efforts in Nigeria
by: Anise N. Happi, et al.
Published: (2022-10-01)

Assessment of knowledge on Lassa fever disease among caregivers presenting to a tertiary Institution in a Lassa fever endemic region, Southeast Nigeria
by: Maria-lauretta Chito Orji, et al.
Published: (2022-03-01)

Current perspectives on vaccines and therapeutics for Lassa Fever
by: Bryce M. Warner, et al.
Published: (2024-12-01)